QQ客服 官方微博 反馈留言

	Corrigendum to “Protective effects of higenamine combined with [6]-gingerol against doxorubicin-induced mitochondrial dysfunction and toxicity in H9c2 cells and potential mechanisms” (Biomedicine & Pharmacotherapy (2019) 115, (S0753332219309965), (10.1016/j.biopha.2019.108881))
	Wen J.[1,2]; Wang J.[1]; Li P.[3]; Wang R.[4]; Wang J.[1]; Zhou X.[5]; Zhang L.[6]; Li H.[2]; Wei S.[2]; Cai H.[2]
	2019
URL标识	查看原文
内容类型	其他
URI标识	http://www.corc.org.cn/handle/1471x/4714667
专题	成都中医药大学
作者单位	1.[1]College of Pharmacy, Provincial and State Key Laboratory Breeding Base of System Research, Development and Utilization of Chinese Herbal Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China 2.[2]Department of Pharmacy, The Fifth Medical Center of PLA General Hospital, Beijing, China 3.[3]China Military Institute of Chinese Medicine, The Fifth Medical Center of PLA General Hospital, Beijing, China 4.[4]Integrative Medical Center, The Fifth Medical Center of PLA General Hospital, Beijing, China 5.[5]Department of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, China 6.[6]College of Pharmacy, Zhejiang University of Chinese Medicine, Hangzhou, China
推荐引用方式 GB/T 7714	Wen J.[1,2],Wang J.[1],Li P.[3],et al. Corrigendum to “Protective effects of higenamine combined with [6]-gingerol against doxorubicin-induced mitochondrial dysfunction and toxicity in H9c2 cells and potential mechanisms” (Biomedicine & Pharmacotherapy (2019) 115, (S0753332219309965), (10.1016/j.biopha.2019.108881)). 2019-01-01.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。